A version of the gene called APOE3 has no effect on Alzheimer's risk, whereas the APOE2
version protects against the disease.
Not exact matches
Using a modified
version of the CRISPR genome - editing system, MIT researchers have developed a new way to screen for genes that
protect against specific
diseases.
The researchers revealed that increasing levels of a certain key protein successfully
protected against cell death in both genetic and sporadic
versions of the
disease.
Research that reveals what goes wrong in SMA and suggests that a mild
version of the same genetic defect may
protect relatives
against infection, which could explain why SMA is relatively common
disease.